Holen Sie sich die Stockscreener-App
13.16
1.35%
-0.18
Handel nachbörslich:
13.28
0.12
+0.91%
Schlusskurs vom Vortag:
$13.34
Offen:
$13.11
24-Stunden-Volumen:
469.72K
Relative Volume:
0.59
Marktkapitalisierung:
$907.08M
Einnahmen:
$46.02M
Nettoeinkommen (Verlust:
$-70.80M
KGV:
-7.2308
EPS:
-1.82
Netto-Cashflow:
$-1.61M
1W Leistung:
-0.68%
1M Leistung:
-1.42%
6M Leistung:
+130.47%
1J Leistung:
+29.40%
1-Tages-Spanne:
$12.86
$13.41
1-Wochen-Bereich:
$12.86
$14.36
52-Wochen-Spanne:
$3.91
$14.91
Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile
Firmenname
Eyepoint Pharmaceuticals Inc
Sektor
Branche
Telefon
617-926-5000
Adresse
480 PLEASANT STREET, WATERTOWN, MA
Vergleichen Sie EYPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EYPT
Eyepoint Pharmaceuticals Inc
|
13.16 | 935.35M | 46.02M | -70.80M | -1.61M | -1.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-07 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-28 | Eingeleitet | Jefferies | Buy |
| 2024-01-22 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-02 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-07-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-03-01 | Eingeleitet | Cowen | Outperform |
| 2021-01-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-04-06 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2019-11-04 | Fortgesetzt | Laidlaw | Buy |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Eyepoint Pharmaceuticals Inc Aktie (EYPT) Neueste Nachrichten
Is EyePoint Pharmaceuticals Inc. stock ready for breakoutRate Cut & Safe Capital Growth Stock Tips - newser.com
Chart based analysis of EyePoint Pharmaceuticals Inc. trendsJuly 2025 Review & Consistent Income Trade Ideas - newser.com
Will EyePoint Pharmaceuticals Inc. stock split attract more investorsJuly 2025 PostEarnings & Verified Chart Pattern Signals - newser.com
Will earnings trigger a reversal in EyePoint Pharmaceuticals Inc.Rate Hike & Precise Swing Trade Entry Alerts - newser.com
What does recent volatility data suggest for EyePoint Pharmaceuticals Inc.July 2025 Macro Moves & Intraday High Probability Alerts - newser.com
EyePoint initiated at buy by Citi on wAMD drug potential - MSN
Using R and stats models for EyePoint Pharmaceuticals Inc. forecastingQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com
Is EyePoint Pharmaceuticals Inc. (PV3B) stock a buy before new product rolloutExit Point & Momentum Based Trading Ideas - newser.com
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Eyepoint Pharmaceuticals' (EYPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
How EyePoint Pharmaceuticals Inc. (PV3B) stock behaves in tightening cyclesVolume Spike & Advanced Technical Signal Analysis - newser.com
Is a relief rally coming for EyePoint Pharmaceuticals Inc. holdersJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
What downside risks could hit EyePoint Pharmaceuticals Inc. (PV3B) stock2025 Market Trends & Low Drawdown Investment Ideas - newser.com
Using Bollinger Bands to evaluate EyePoint Pharmaceuticals Inc.2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com
What analysts say about EyePoint Pharmaceuticals Inc stockReal-Time Stock Alerts & Take Advantage of Momentum Stocks - earlytimes.in
EyePoint Pharmaceuticals Hits New 52-Week High of $14.90 - Markets Mojo
Can EyePoint Pharmaceuticals Inc. (PV3B) stock sustain margin levelsCEO Change & Daily Stock Trend Reports - newser.com
Candlestick signals on EyePoint Pharmaceuticals Inc. stock todayQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-10-03 02:01:33 - newser.com
Sentiment analysis tools applied to EyePoint Pharmaceuticals Inc.Trade Volume Summary & Low Drawdown Momentum Ideas - newser.com
Mizuho Securities Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛
EyePoint stock rating reiterated at Outperform by Mizuho amid competitor review - Investing.com
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Hits New 1-Year HighHere's Why - MarketBeat
EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Up 4%Time to Buy? - MarketBeat
Detecting support and resistance levels for EyePoint Pharmaceuticals Inc.July 2025 Market Mood & Momentum Based Trading Ideas - newser.com
Published on: 2025-09-29 08:12:16 - newser.com
What analysts say about EyePoint Pharmaceuticals Inc PV3B stockLong-Term Investment Plans & Low Cost Wealth Building - earlytimes.in
Biotech Stocks Rally. 3 Favorite Plays From the Charts. - Barron's
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Published on: 2025-09-22 08:23:21 - خودرو بانک
Finanzdaten der Eyepoint Pharmaceuticals Inc-Aktie (EYPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):